The Supreme Court temporarily restored telehealth and mail access to the abortion pill mifepristone on May 4, following an emergency appeal from pro-choice and pro-life groups. This move has sparked debate over whether mailing the drug should be allowed. Mifepirstone, approved by the Food and Drug Administration in 2000, has been used by millions of people for 25 years and is proven safe and effective. Laura Chapin from Cobalt, a reproductive rights advocacy group, challenged the necessity of in-person medical supervision for the medication. Robyn Chambers from Focus on the Family expressed concerns about women's safety and safety, particularly when obtained by mail. She also suggested that a permanent ban on abortion pills being sent through the mail was needed due to safety concerns.